Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Chubb
Farmers Insurance
Moodys
Deloitte
Cerilliant
McKinsey
Merck
Queensland Health

Generated: November 12, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Losmapimod

« Back to Dashboard

US Patents for Losmapimod

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Losmapimod ➤ Sign Up Nicotinamide derivatives useful as p38 inhibitors. SmithKline Beecham Corporation (Philadelphia, PA) ➤ Sign Up
Losmapimod ➤ Sign Up Nicotinamide derivatives useful as p38 inhibitors SmithKline Beecham Corporation (Philadelphia, PA) ➤ Sign Up
Losmapimod ➤ Sign Up Nicotinamide derivatives useful as p38 inhibitors GlaxoSmithkline LLC (Philadelphia, PA) ➤ Sign Up
Losmapimod ➤ Sign Up 3-aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as p38 kinase inhibitors GlaxoSmithKline LLC (Philadelphia, PA) ➤ Sign Up
Losmapimod ➤ Sign Up Use of a p38 kinase inhibitor for treating psychiatric disorders GlaxoSmithKline LLC (Philadelphia, PA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Losmapimod

Drugname Country Document Number Estimated Expiration Related US Patent
Losmapimod Austria 375980 2022-02-12 ➤ Sign Up
Losmapimod Austria 485275 2022-02-12 ➤ Sign Up
Losmapimod Australia 2003207298 2022-02-12 ➤ Sign Up
Losmapimod Brazil 0307351 2022-02-12 ➤ Sign Up
Losmapimod Canada 2474192 2022-02-12 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Teva
Argus Health
Daiichi Sankyo
Merck
Harvard Business School
Queensland Health
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.